Logo

European Researchers to Use RNAi for Cell Division Study Funded with EUR 8.5M from EU

Jul 16, 2004

NEW YORK, July 16 (GenomeWeb News) - A consortium of European researchers has received €8.5 million in funding from the European Union to study cell division, in part by using RNA interference, the European Molecular Biology Laboratory said yesterday.

 

The project, called MitoCheck, includes researchers at EMBL, the Max Planck Institute of Cell Biology and Genetics in Dresden, the Wellcome Trust Sanger Institute, and nine other research institutes in Austria, Germany, Italy, France, and the UK.

 

EMBL scientists plan to study the effects on cell division of suppressing 20,000 genes, one by one, using RNA interference. The MPI in Dressden will provide a library of RNAi molecules. Other partners in the project will use the information to determine the biological regulation of cell division genes.

 

The funding comes from the European Commission's 6th Framework Program.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.